Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study-Reference-Cited by-同舟云学术

Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study

Published:2020-10-22 Issue:5 Volume:36 Page:1235-1243
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Pyo Jeung Hui¹,Kim Tae Jun²^ORCID,Lee Hyuk²^ORCID,Choi Sung Chul¹,Cho Soo‐Jin¹,Choi Yoon‐Ho¹,Min Yang Won²,Min Byung‐Hoon²,Lee Jun Haeng²,Kang Minwoong³,Lee Yeong Chan³,Kim Jae J²

Affiliation:

1. Center for Health Promotion, Samsung Medical Center, School of Medicine Sungkyunkwan University Seoul South Korea

2. Department of Medicine, Samsung Medical Center, School of Medicine Sungkyunkwan University Seoul South Korea

3. Department of Digital Health, SAIHST, School of Medicine Sungkyunkwan University Seoul South Korea

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15236

Reference40 articles.

1. 25 Years of Proton Pump Inhibitors: A Comprehensive Review

2. Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?

3. Proton Pump Inhibitor Use and Enteric Infections

4. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

5. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitor use is associated with increased liver steatosis;Biomedical Reports;2024-06-13

2. Endogenous ethanol production in health and disease;Nature Reviews Gastroenterology & Hepatology;2024-06-03

3. Alterations in gut microbiota and bile acids by proton‐pump inhibitor use and possible mediating effects on elevated glucose levels and insulin resistance;The FASEB Journal;2024-03-18

4. Research Progress of the Effects of Long-Term Use of Proton Pump Inhibitors on Non-Alcoholic Fatty Liver Disease;Advances in Clinical Medicine;2024

5. New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk;Nutrients;2023-09-14